CAM
CRGX

Cormorant Asset Management’s CARGO Therapeutics CRGX Stock Holding History

Cormorant Asset Management’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,381,277
Closed -$13.9M – 37
2025
Q2 		$13.9M Hold
3,381,277
– – 1.04% 23
2025
Q1 		$13.8M Buy
3,381,277
+2,198,714
+186% +$14.7M 1.03% 23
2024
Q4 		$17.1M Hold
1,182,563
– – 0.94% 25
2024
Q3 		$21.8M Hold
1,182,563
– – 1.16% 26
2024
Q2 		$19.4M Hold
1,182,563
– – 1.12% 28
2024
Q1 		$26.4M Hold
1,182,563
– – 1.16% 29
2023
Q4 		$27.4M Buy
+1,182,563
New +$20.1M 1.31% 23

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cormorant Asset Management's CRGX Position: Q3 2025 in Review

Cormorant Asset Management sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 3,381,277 shares — an estimated $13.9M sold.

Cormorant Asset Management first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $27.4M in Q4 2023. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Cormorant Asset Management reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cormorant Asset Management sold 3,381,277 CARGO Therapeutics shares in Q3 2025, an estimated $13.9M.
  • Cormorant Asset Management first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
  • Cormorant Asset Management's CARGO Therapeutics position peaked at $27.4M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Cormorant Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.